References
- Lichtenstein LM. An evaluation of the role of immunotherapy in asthma. Am Rev Respir Dis 1978: 117(2): 191–7
- Piper PJ. Pharmacology and biochemistry of the leukotrienes. Eur J Respir Dis 1982: 63(Suppl 1122): 54–61
- Guidelines for bronchial inhalation challenges with pharmacologic and antigen agents. Am Thorac Soc News 1980: 6: 11
- Leifer KN, Wlttig HJ. The beta2 sympathomimetic aerosols in the treatment of asthma. Am Allergy 1975: 35: 69–80
- Tobin MJ, Jenouri G, Danta I, et al. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis 1982: 126: 670–5
- Pakes GE, Brogden RN, Heel RC, et al. ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 1980: 20(4): 237–66
- Mattson K, Poppius H, Nikander-Hurme R. Preventive effect of ketotifen. a new antiallergic agent, on histamine-induced bronchoconstriction in asthmatics. Clin Allergy 1979: 9(4): 411–6
- Fischl MA, Pitchenik A, Gardner LB. An Index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N Engl J Med 1981: 305 (14): 783–9
Suggested readings
- Epstein SW, Middleton EW, eds. Advances in assessment and therapy of asthma Chest 1982: 82(Suppl)
- Hogg JC, Paie PD, Boucher RC, et al. The pathophysiology of asthma. Can Med Assoc J 1979: 121: 409–14
- Paterson JW. Woolcock AJ. Shenfield GM. Bronchodilators. Am Rev ResDir Dis 1979: 120: 1149–88